Companies in the Genome editing industry
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Pfizer is an American, multinational pharmaceutical and biotechnology corporation. | ||||||
Novartis is a healthcare and pharmaceutical company based in Basel, Switzerland, incorporated in 1996. | ||||||
Sanofi is a french pharmaceutical company founded in 2004 by Madhukar Reddy. | ||||||
Bristol-Myers Squibb is a large US pharmaceutical company that develops and distributes medicines in the categories of cancer, HIV, analgesics, antibiotics, and cardiology. | ||||||
Eli Lilly is an american global pharmaceutical company founded in 1876 by Eli Lilly. | ||||||
German multinational pharmaceutical, chemical, and agricultural biotechnology company | ||||||
AstraZeneca is a global biopharmaceutical business founded in 1999. | ||||||
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics. | ||||||
Novo Nordisk is a danish company founded in 1923 by David Thompson, August Krogh and Hans Christian Hagedorn. | ||||||
Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz. | ||||||
Vertex Pharmaceuticals discovers, develops and commercializes pharmaceutical products for treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease and neurological disorders. | ||||||
A biopharmaceutical company developing, manufacturing and commercializing medicines for treating serious medical conditions. | ||||||
A biotechnology startup company that develops messenger RNA based therapeutics to treat diseases. | ||||||
Takeda Pharmaceutical Company is a company that provides research-based healthcare and medical products | ||||||
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology. | ||||||
Allogene Therapeutics is a San Francisco, California-based biotechnology company specializing in the development of allogeneic CAR T("AlloCAR TTM") therapies for cancer. | ||||||
A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K. | ||||||
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity. | ||||||
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products. | ||||||
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine. | ||||||
A biotechnology that specializes in genome editing, gene therapy, cell therapy and gene regulation. | ||||||
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products. | ||||||
Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard. | ||||||
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes. | ||||||
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines. |
